ADAM10 inhibits the interaction between IL-17 and HMGB1 in Buerger's disease.
Sign Up to like & getrecommendations! Published in 2021 at "European review for medical and pharmacological sciences"
DOI: 10.26355/eurrev_202106_26046
Abstract: OBJECTIVE Buerger's disease is a rare disease that causes critical limb ischemia; however, the underlying pathophysiological mechanism remains unclear. Therefore, we investigated the interaction between interleukin (IL)-17 and high-mobility group protein B 1 (HMGB1) and… read more here.
Keywords: buerger disease; disease; interaction hmgb1;